Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Flat Quarter Can't Spoil Record Year for Pittsburgh-Based Drug Maker Mylan.
- By Jim McKay, Pittsburgh Post-Gazette Knight Ridder/Tribune Business News May 12--Pittsburgh-based drug maker Mylan Laboratories posted a flat fourth quarter yesterday, but said earnings for its full fiscal year jumped 23 percent to a record. The company said it...
- Research articles 2004-05-12
- The Agenda Behind Mylan's Suit v. the Pittsburgh Post-Gazette
- Mylan is suing two reporters and their employer, the Pittsburgh Post-Gazette, for the story it ran detailing alleged abuses of computer safety protocols at one of its factories. There's an agenda behind what's going on here; the paper and Mylan management have a longstanding beef that predates the recent story...
- Blog posts 2009-08-19
- Mylan Seeks Names of Moles; Internal Probe Failed to Find Them
- Mylan is looking for the internal moles who leaked documents to the Pittsburgh Post-Gazette about workers who overrode manufacturing software at its Morgantown. Va., plant. Mylan sued the newspaper after it wrote a series of stories about the company based on leaked documents. by Jim Edwards
- Blog posts 2009-08-20
- Mylan CFO Exits; Analyst Asks: "What Is Wrong Inside The Company?"
- Mylan's new CFO has left the job after just three months. Her departure follows an (as-yet) unrelated manufacturing controversy at Mylan, and an internal probe to find the mole who leaked internal documents about safety procedures at Mylan to the press. by Jim Edwards
- Blog posts 2009-09-09
- Mylan Suit Is a Witchhunt for Company's Internal Moles, Paper Claims
- Mylan's lawsuit against the Pittsburgh Post-Gazette is nothing but an extension of its internal witch-hunt for the identities of executives who have been leaking information to the paper, the P-G claims. by Jim Edwards
- Blog posts 2009-10-01
- Mylan's Halloween Scare Message: Candy May Kill Your Kids!
- Mylan's pre-Halloween press release came on like a pharmaceutical version of the urban legend of the razor blade in the apple. The headline says: "For Parents of Kids with Food Allergies, the Scariest Thing at Halloween is the Trick-or-Treat Bag." by Jim Edwards
- Blog posts 2009-11-03
Additional Resources
- Mylan Names Sharad K. Govil President of Mylan Technologies Inc
- Business Editors PITTSBURGH--BUSINESS WIRE--Oct. 2, 2001 Mylan Laboratories Inc. (NYSE:MYL) announced today that Sharad K. Govil, Ph.D., has been named president of Mylan Technologies Inc. Dr. Govil will be responsible for the development, manufacturing and international business development of Mylan Technologies' drug delivery systems and components business....
- Research articles 2001-10-02
- VERAPAMIL.(Mylan Laboratories Inc. has received FDA approval to manufacture hypertension medicine)(Brief Article)
- Mylan Laboratories Inc. has received FDA approval to manufacture verapamil hydrochloride extended release capsules in 120 mg, 180 mg and 240 mg strengths for the management of essential hypertension. Mylan ... Mylan Laboratories Inc. has received FDA approval to manufacture verapamil hydrochloride extended...
- Research articles 1999-05-24
- Mylan Fined $135 Million.(Brief Article)(Statistical Data Included)
- MYLAN LABORATORIES Inc. reached a tentative settlement last week with Federal Trade Commission and state attorneys general over price-fixing lawsuits filed against the company in December 1998. Mylan has agreed to pay a $135 million settlement and MYLAN LABORATORIES Inc. reached a tentative...
- Research articles 2000-07-17
- Mylan wins FDA approval for generic Accutane. (Markets: Life Sciences).(Brief Article)
- MYLAN LABORATORIES Inc. has received Food and Drug Administration FDA approval for its generic version of Roche's acne drug Accutane/Roaccutan isotretinoin. Mylan's branded subsidiary Bertek Pharmaceuticals Inc. will market isotretinoin u MYLAN LABORATORIES Inc. has received Food and...
- Research articles 2002-11-18
- Hedge fund thwarts Icahn's ploy at Canonsburg, Pa., generic drug maker Mylan.
- By Len Boselovic, Pittsburgh Post-Gazette Knight Ridder/Tribune Business News Nov. 30--Billionaire investor Carl Icahn has been unseated as Mylan Laboratories' largest stockholder by a New York hedge fund out to make sure the Mylan acquisition of King Pharmaceuticals will be consummated....
- Research articles 2004-11-30
- MYLAN.(Mylan Laboratories Inc.)(Brief Article)
- MYLAN Laboratories Inc. has received FDA approval to manufacture and market a generic version of Bristol-Myers Squibb's Buspar buspirone. Last week, a federal circuit court lifted a temporary ... MYLAN Laboratories Inc. has received FDA approval to manufacture and market a generic version of...
- Research articles 2001-04-02
- MYLAN LABORATORIES.
- MYLAN LABORATORIES has filed a motion with the D.C. District Court to dismiss charges of monopolization and restraint of trade brought against the company by the Federal Trade Commission and 32 state ... MYLAN LABORATORIES has filed a motion with the D.C. District Court...
- Research articles 1999-03-22
- MYLAN.(MYLAN Laboratories Inc)(Brief Article)
- MYLAN Laboratories Inc. reported its third quarter earnings for 2000. Net sales were $203.9 million, a 10 percent increase over net ... MYLAN Laboratories Inc. reported its third quarter earnings for 2000. Net sales were $203.9 million, a 10 percent increase over net ...
- Research articles 2000-01-31
- Mylan Named in Class Action Suits.(Mylan Laboratories)
- TWELVE STATES have filed class-action Lawsuits against Mylan Laboratories following the Federal Trade Commission's decision to sue the company for alleged antitrust violations involving the supply of two antianxiety drugs, lorazepam and clorazepate TWELVE STATES have filed class-action Lawsuits against Mylan Laboratories following...
- Research articles 1999-01-04
- MYLAN Laboratories Inc.(Brief Article)
- MYLAN Laboratories Inc. has received FDA approval to manufacture and market carbidopa and levodopa ... MYLAN Laboratories Inc. has received FDA approval to manufacture and market carbidopa and levodopa extended-release tablets in 25 mg/l00 mg strength. The product is being manufactured at Mylan's ...
- Research articles 2000-05-08
- Mylan to take controlling stake in India's Matrix
- WASHINGTON AFP — US generic drugmaker Mylan Laboratories said it would acquire up to 71.5 percent of India's Matrix Laboratories for around 736 million dollars (575 million euros). Matrix will provide Mylan with a significant presence in emerging pharmaceutical markets, including India, China, and Africa, as well as a European...
- Research articles 2006-08-28
- Mylan Opens New Greensboro Distribution Center
- PITTSBURGH--BUSINESS WIRE--Feb. 26, 1998--Mylan Laboratories Inc. announced today the grand opening of a new distribution center in Greensboro, N.C. The center is strategically located on 126 acres in southeast Greensboro. Milan Puskar, chairman, C.E.O., and president of the company, commented that "This distribution center...
- Research articles 1998-02-26
- Mylan Signs Licensing Agreement
- PITTSBURGH--BUSINESS WIRE--June 29, 1998--Mylan Laboratories Inc. (NYSE:MYL) announced today that they have reached agreement with 3M Pharmaceuticals for an exclusive license to sell Orphenadrine Citrate Extended-Release Tablets, 100 mg.Mylan Label Orphenadrine Citrate is therapeutically equivalent to NorflexR, a 3M Pharmaceuticals product which is used in the treatment of acute painful...
- Research articles 1998-06-29
- Mylan on the Comeback Trail
- Alpha TimerAllen Phatimer submits: Ideas that are somewhat countercyclical in nature but also have a good chance of support from industry specific trends and/or company specific dynamics which can yield cash flow and earnings acceleration lead to me like Mylan MYL. I view this as an out of favor name...
- External links 2008-11-28
- << Previous
- page 1 of 1
- Next >>
